Jo Young-Il, Song Jong-Oh, Park Jung-Hwan, Lee Jong-Ho, Shin Sug Kyun
Division of Nephrology, Department of Internal Medicine, School of Medicine, Konkuk University, Seoul, Korea.
Nephrology (Carlton). 2007 Oct;12(5):437-40. doi: 10.1111/j.1440-1797.2007.00794.x.
Peritoneal fluid eosinophilia (PFE), which is classically associated with idiopathic eosinophilic peritonitis (EP), has been known as a common event in patients on continuous ambulatory peritoneal dialysis (CAPD). However, our recent retrospective study of CAPD patients following percutaneous catheter placement showed that PFE occurred rarely. The aim of this prospective study was to clarify the incidence and characteristics of idiopathic EP and PFE in patients on CAPD following percutaneous catheter placement.
Forty-eight patients on CAPD following percutanous catheter placement were recruited for the present study. Peritoneal dialysis was initiated immediately after catheter insertion without break-in period. A cytological study of dialysate was performed on days 1, 2, 3, 4, 5, 6, 7, 14 and 30 after initiation of CAPD, and then monthly for 6 months. In addition, a cytological study was performed also when a patient revealed abdominal pain or cloudy peritoneal effluent.
PFE developed in three (6.3%) patients during the study period. The incidence of idiopathic EP and PFE without any clinical findings suggestive of PD-related peritonitis was 2.1% and 4.2% respectively. All cases of PFE, including idiopathic EP, developed on a mean of 13 day following initiation of CAPD and resolved spontaneously after a mean of 7 days. There was no significant difference in IgE levels or the occurrence of peripheral blood eosinophilia between patients with PFE and those without.
Idiopathic EP is infrequent among patients on CAPD following percutaneous catheter placement, but should be differentiated from infectious PD-related peritonitis.
腹腔积液嗜酸性粒细胞增多症(PFE),传统上与特发性嗜酸性粒细胞性腹膜炎(EP)相关,在持续性非卧床腹膜透析(CAPD)患者中是常见现象。然而,我们最近对经皮导管置入术后CAPD患者的回顾性研究表明,PFE很少发生。本前瞻性研究的目的是明确经皮导管置入术后CAPD患者特发性EP和PFE的发生率及特征。
本研究招募了48例经皮导管置入术后的CAPD患者。导管插入后立即开始腹膜透析,无磨合期。在CAPD开始后的第1、2、3、4、5、6、7、14和30天对透析液进行细胞学研究,然后在接下来的6个月每月进行一次。此外,当患者出现腹痛或腹膜透析液浑浊时也进行细胞学研究。
在研究期间,3例(6.3%)患者出现了PFE。无任何提示与腹膜透析相关腹膜炎临床症状的特发性EP和PFE的发生率分别为2.1%和4.2%。所有PFE病例,包括特发性EP,均在CAPD开始后平均13天出现,平均7天后自发缓解。PFE患者和无PFE患者之间的IgE水平或外周血嗜酸性粒细胞增多症的发生率无显著差异。
经皮导管置入术后的CAPD患者中特发性EP并不常见,但应与感染性腹膜透析相关腹膜炎相鉴别。